Transformational Leaders in BioPharmaceutical

  • Rajesh Malik, MD
    Chief Medical Officer
    Adherex Technologies, Inc
  • Nancy Grygiel
    Sr. Director, Corporate Compliance
    Allergan
  • William Glass, PhD
    Sr. Director, Publications, Global Medical Affairs
    Allergan
  • Wes Porter
    VP, Deputy Compliance Officer
    Allergan
  • Steve Damon
    VP, Business Development
    Altea Therapeutics
  • Tom Weber, PhD
    Sr. Director, Analytical Chemistry
    Angiotech Pharmaceuticals
  • Chris Dennis
    Sr. VP, Sales & Marketing
    Angiotech Pharmaceuticals
  • Jeff Gross, PhD
    VP of Engineering
    Angiotech Pharmaceuticals
  • Tim Lowinger, PhD
    VP, Pharmaceutical Science & Chemistry
    Angiotech Pharmaceuticals
  • Andrew Penman, PhD
    VP, Preclinical Development
    Angiotech Pharmaceuticals
  • Jerry Fernandez, MD
    Sr. Director of Pathology
    Aureon Biosciences
  • Steve Hamburger, PhD
    VP, Clinical & Regulatory Affairs
    Exoxemis, Inc
  • Russ Ellison, MD
    VP, Clinical Development
    Fibrogen
  • Cathy Srebalus-Barnes, PhD
    Sr. Director, Bioanalytical Sciences Global Biologics R&D
    Hospira
  • Kurt Gunter, MD
    Cell Therapy Initiatives
    Hospira
  • Peter Lacouture, PhD
    Medical Director, Pain Management
    Hospira
  • Neil Schauer, PhD
    Sr. Director, Biologics Process Development
    Hospira
  • Tom Nikolai
    Sr. Director, External Biologics Collaborations & Partnerships
    Hospira
  • Scott Treiber, PhD
    VP, Clinical Operations & Medical Affairs
    Hospira
  • Carol Gallagher
    CEO
    Metastatix, Inc
  • Charles Deignan
    Chief Financial Officer
    Metastatix, Inc
  • Tom Hochuli
    VP, Manufacturing
    MiMedx Group
  • Jon Hopper, MB ChB
    Chief Medical Officer
    Osiris Therapeutics
  • Lode Debrabandere, PhD
    General Manager, Autoimmune Business Unit
    Osiris Therapeutics
  • Bill Wright
    Sr. Director, Osteocel and Mesenchymal Stem Cell Operations
    Osiris Therapeutics
  • Ross Tonkens, MD
    Chief Medical Officer
    Regado Biosciences
  • James Klein
    Chief Financial Officer
    Adherex
  • Brian Huber, PhD
    Chief Scientific Officer
    Adherex
  • Edward Cannon, PhD
    CEO
    Aerovectrx Corporation
  • David Enscore
    Sr. VP, Product R&D
    Altea Therapeutics
  • John Hannon
    Chief Operating Officer
    Exoxemis
  • Shelley Hartman
    President, CEO
    GMP Companies, Inc
  • Tom Vanden Boom, PhD
    Global Pharmaceuticals VP of Biologics R&D
    Hospira
  • Sam Helgerson, PhD
    VP, R&D
    Symphony Medical
  • Tina Webb
    Director, Business Compliance, Pharmaceuticals
    Allergan
  • Courtney Barton
    Director, Corporate Compliance
    Allergan
  • Stan Harris
    VP, Clinical Operations
    MiMedx Group
  • Yanshan Ma, MD, PhD
    Senior Director, Medical Safety Physician
    Allergan
  • Michel Hermans, MD
    Chief Medical Officer
    TissueTech
  • Chris Stein, MD, PhD
    Director, Medical Safety Physician
    Allergan

CLIENT NEWS

KEY CONFERENCES

INDUSTRY ORGANIZATIONS

CANDIDATE ACCESS